Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 574

1.

Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study.

Dierssen-Sotos T, Gómez-Acebo I, de Pedro M, Pérez-Gómez B, Servitja S, Moreno V, Amiano P, Fernandez-Villa T, Barricarte A, Tardon A, Diaz-Santos M, Peiro-Perez R, Marcos-Gragera R, Lope V, Gracia-Lavedan E, Alonso MH, Michelena-Echeveste MJ, Garcia-Palomo A, Guevara M, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Llorca J.

BMC Cancer. 2016 Aug 20;16(1):660. doi: 10.1186/s12885-016-2692-4.

2.

The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.

Gómez-Acebo I, Dierssen-Sotos T, Palazuelos C, Pérez-Gómez B, Lope V, Tusquets I, Alonso MH, Moreno V, Amiano P, Molina de la Torre AJ, Barricarte A, Tardon A, Camacho A, Peiro-Perez R, Marcos-Gragera R, Muñoz M, Michelena-Echeveste MJ, Ortega Valin L, Guevara M, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Llorca J.

PLoS One. 2016 Aug 10;11(8):e0159672. doi: 10.1371/journal.pone.0159672. eCollection 2016.

3.

Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients.

Kehlet SN, Sanz-Pamplona R, Brix S, Leeming DJ, Karsdal MA, Moreno V.

Sci Rep. 2016 Jul 28;6:30599. doi: 10.1038/srep30599.

4.

False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.

Ibañez-Sanz G, Garcia M, Milà N, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Benito L, Padrol I, Barenys M, Moreno V.

Eur J Cancer Prev. 2016 Jul 18. [Epub ahead of print]

PMID:
27433880
5.

Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy.

Moral A, Moreno V, Girón F, El-Qutob D, Moure JD, Alcántara M, Padial A, Oehling AG, Millán C, de la Torre F.

J Asthma Allergy. 2016 Jun 29;9:129-33. doi: 10.2147/JAA.S107830. eCollection 2016.

6.

Colorectal Cancer and Long-Term Exposure to Trihalomethanes in Drinking Water: A Multicenter Case-Control Study in Spain and Italy.

Villanueva CM, Gracia-Lavedan E, Bosetti C, Righi E, Molina AJ, Martín V, Boldo E, Aragonés N, Perez-Gomez B, Pollan M, Gomez Acebo I, Altzibar JM, Jiménez Zabala A, Ardanaz E, Peiró R, Tardón A, Chirlaque MD, Tavani A, Polesel J, Serraino D, Pisa F, Castaño-Vinyals G, Espinosa A, Espejo-Herrera N, Palau M, Moreno V, La Vecchia C, Aggazzotti G, Nieuwenhuijsen MJ, Kogevinas M.

Environ Health Perspect. 2016 Jul 6. [Epub ahead of print]

7.

Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.

Ibáñez-Sanz G, Garcia M, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Domènech X, Vidal C, Soriano A, Moreno V; ‘Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study’ Working Group.

Dig Liver Dis. 2016 Jun 21. pii: S1590-8658(16)30470-4. doi: 10.1016/j.dld.2016.06.011. [Epub ahead of print]

PMID:
27378703
8.

Experimental and theoretical studies of copper complexes with isomeric dipeptides as novel candidates against breast cancer.

Facchin G, Veiga N, Kramer MG, Batista AA, Várnagy K, Farkas E, Moreno V, Torre MH.

J Inorg Biochem. 2016 Jun 4. pii: S0162-0134(16)30156-8. doi: 10.1016/j.jinorgbio.2016.06.005. [Epub ahead of print]

PMID:
27369466
9.

Algorithmic methods to infer the evolutionary trajectories in cancer progression.

Caravagna G, Graudenzi A, Ramazzotti D, Sanz-Pamplona R, De Sano L, Mauri G, Moreno V, Antoniotti M, Mishra B.

Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):E4025-34. doi: 10.1073/pnas.1520213113. Epub 2016 Jun 28.

PMID:
27357673
10.

Night shift work and stomach cancer risk in the MCC-Spain study.

Gyarmati G, Turner MC, Castaño-Vinyals G, Espinosa A, Papantoniou K, Alguacil J, Costas L, Pérez-Gómez B, Martin Sanchez V, Ardanaz E, Moreno V, Gómez-Acebo I, Fernández-Tardon G, Villanueva Ballester V, Capelo R, Chirlaque MD, Santibáñez M, Pollán M, Aragonés N, Kogevinas M.

Occup Environ Med. 2016 Aug;73(8):520-7. doi: 10.1136/oemed-2016-103597. Epub 2016 Jun 16.

PMID:
27312400
11.

Pivotal role for skin transendothelial radio-resistant anti-inflammatory macrophages in tissue repair.

Barreiro O, Cibrian D, Clemente C, Alvarez D, Moreno V, Valiente Í, Bernad A, Vestweber D, Arroyo AG, Martín P, von Andrian UH, Sánchez Madrid F.

Elife. 2016 Jun 15;5. pii: e15251. doi: 10.7554/eLife.15251.

12.

Downregulation of the Deiminase PADI2 is an Early Event in Colorectal Carcinogenesis and Indicates Poor Prognosis.

Cantarino N, Musulen E, Valero V, Peinado MA, Perucho M, Moreno V, Forcales SV, Douet J, Buschbeck M.

Mol Cancer Res. 2016 Jun 8. pii: molcanres.0034.2016. [Epub ahead of print]

PMID:
27280713
13.

MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer.

Caramés C, Cristobal I, Moreno V, Marín JP, González-Alonso P, Torrejón B, Minguez P, Leon A, Martín JI, Hernández R, Pedregal M, Martín MJ, Cortés D, García-Olmo D, Fernández MJ, Rojo F, García-Foncillas J.

Int J Mol Sci. 2016 Jun 3;17(6). pii: E878. doi: 10.3390/ijms17060878.

14.

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib.

Mateo J, Moreno V, Gupta A, Kaye SB, Dean E, Middleton MR, Friedlander M, Gourley C, Plummer R, Rustin G, Sessa C, Leunen K, Ledermann J, Swaisland H, Fielding A, Bannister W, Nicum S, Molife LR.

Target Oncol. 2016 Jun;11(3):401-15. doi: 10.1007/s11523-016-0435-8.

PMID:
27169564
15.

TOMATO AGAMOUS1 and ARLEQUIN/TOMATO AGAMOUS-LIKE1 MADS-box genes have redundant and divergent functions required for tomato reproductive development.

Gimenez E, Castañeda L, Pineda B, Pan IL, Moreno V, Angosto T, Lozano R.

Plant Mol Biol. 2016 Jul;91(4-5):513-31. doi: 10.1007/s11103-016-0485-4. Epub 2016 Apr 28.

PMID:
27125648
16.

Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles.

Cejas P, Li L, O'Neill NK, Duarte M, Rao P, Bowden M, Zhou CW, Mendiola M, Burgos E, Feliu J, Moreno-Rubio J, Guadalajara H, Moreno V, García-Olmo D, Bellmunt J, Mullane S, Hirsch M, Sweeney CJ, Richardson A, Liu XS, Brown M, Shivdasani RA, Long HW.

Nat Med. 2016 Jun;22(6):685-91. doi: 10.1038/nm.4085. Epub 2016 Apr 25.

PMID:
27111282
17.

Erratum: Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposis.

Mur P, Sánchez-Cuartielles E, Aussó S, Aiza G, Valdés-Mas R, Pineda M, Navarro M, Brunet J, Urioste M, Lázaro C, Moreno V, Capellá G, Puente XS, Valle L.

Sci Rep. 2016 Apr 20;6:23880. doi: 10.1038/srep23880. No abstract available.

18.

A single case report of MR-guided focused ultrasound thalamotomy for tremor in fragile X-associated tremor/ataxia.

Cerquera C, Rumià J, Herrera JM, Moreno V, Bargalló N, Valldeoriola F.

Parkinsonism Relat Disord. 2016 Jul;28:159-60. doi: 10.1016/j.parkreldis.2016.04.002. Epub 2016 Apr 4. No abstract available.

PMID:
27066991
19.

Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies.

Azuara D, Santos C, Lopez-Doriga A, Grasselli J, Nadal M, Sanjuan X, Marin F, Vidal J, Montal R, Moreno V, Bellosillo B, Argiles G, Elez E, Dienstmann R, Montagut C, Tabernero J, Capellá G, Salazar R.

Mol Cancer Ther. 2016 May;15(5):1106-12. doi: 10.1158/1535-7163.MCT-15-0820. Epub 2016 Apr 1.

PMID:
27037411
20.

A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies.

Mateo J, Olmos D, Dumez H, Poondru S, Samberg NL, Barr S, Van Tornout JM, Jie F, Sandhu S, Tan DS, Moreno V, LoRusso PM, Kaye SB, Schöffski P.

Br J Cancer. 2016 Apr 12;114(8):889-96. doi: 10.1038/bjc.2016.59. Epub 2016 Mar 22.

PMID:
27002938
Items per page

Supplemental Content

Loading ...
Write to the Help Desk